Blanket Purchase Agreement 36C25926A0004

Award Date 10/1/25
Last Date to Order 9/30/30
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Act
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 17 to Mdxhealth, Inc., a for-profit healthcare company specializing in cancer diagnostics. The BPA, with a total ceiling value of $4,800,000, is for the provision of Oncotype DX prostate cancer testing services under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract. The period of performance...
This federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the Veterans Integrated Service Network 17 (VISN 17) of the Department of Veterans Affairs (VA) to Mdxhealth, Inc., a for-profit healthcare company that provides molecular diagnostic services. The BPA, issued under Mdxhealth's existing General Services Administration (GSA) Federal Supply Schedule contract for Medical Laboratory Testing and Analysis Services, has a ceiling value of $320,000 and a period of performance...
This federal contract Indefinite Delivery Vehicle (IDV) is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) to Mdxhealth, Inc., a for-profit healthcare company based in Irvine, California. The contract, valued at up to $755,655.00, is for the provision of prostate cancer testing services under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The BPA has a period of performance from July 1, 2022 through...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a Blanket Purchase Agreement (BPA) to Mdxhealth, Inc., a for-profit healthcare company, for the provision of specialized cancer diagnostic testing services. The BPA is under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract (FSS-621-II) and has a total potential value of $280,000 with an ultimate completion date of April 2, 2029. Specifically, the BPA covers DX Prostate Testing,...
The U.S. Department of Veterans Affairs (VA), through its Veterans Integrated Service Network (VISN) 19, has awarded a series of Blanket Purchase Agreement (BPA) call contracts to Mdxhealth, Inc., a for-profit healthcare company specializing in molecular diagnostic services and cancer testing. The contracts, valued at over $500,000 total, are for the provision of MDX health testing and analysis services to support the VA's healthcare programs for veterans. The contracts were awarded under the...
This federal contract Indefinite Delivery Vehicle (IDV) is a Multiple Award Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Mdxhealth, Inc., a for-profit healthcare company. The contract, valued at up to $3,194,250.75, is for the provision of medical laboratory testing and analysis services, with a specific focus on advanced molecular diagnostic testing for cancer. Mdxhealth offers specialized genetic and epigenetic testing services such as...
This Blanket Purchase Agreement (BPA) is a single-award federal contract vehicle administered by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 17 to procure cancer diagnostic testing services from MdxHealth, Inc., a for-profit healthcare company. The BPA calls for MdxHealth to provide its MDXHEALTH GPS molecular diagnostic services, which utilize genetic and epigenetic biomarkers to support personalized diagnosis and treatment for various cancers...
This federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 to Exact Sciences Corporation, a for-profit medical technology company. The BPA, valued at $4,000,000, is established under the Medical Laboratory Testing and Analysis Services (FSS-621-II) Federal Supply Schedule and has an ultimate completion date of August 17, 2028. The primary purpose of this contract is to provide Oncotype DX cancer...
The federal contract IDV award is a Blanket Purchase Agreement (BPA) issued by the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 17, a civilian agency, to Quest Diagnostics Incorporated, a large diagnostic information services provider. The BPA, valued at $4,674,582.70, covers a 5-year period of performance from February 2021 to February 2026 and is under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The BPA and associated...
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 19 (VISN 19) to Exact Sciences Corporation, a for-profit medical technology company. The contract, valued at $919,774.30, is for the provision of Genomic Health genetic testing services, primarily the Oncotype DX gene expression profiling test, to VISN 19 healthcare facilities. The contract utilizes the Medical Laboratory Testing and Analysis Services (FSS-621-II)...
  • 36C25926A0004
    Blanket Purchase Agreement
  • 1
    Federal Contract Awards

The federal contract IDV award is a single-award Blanket Purchase Agreement (BPA) issued by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 19 (VISN 19) to MDXHealth, Inc., a for-profit healthcare company specializing in molecular diagnostic services for cancer testing and analysis. The $1,424,021.22 BPA, awarded on October 1, 2025 with a performance period through September 30, 2030, enables VISN 19 to efficiently procure MDXHealth's specialized cancer diagnostic services, including Oncotype DX, GPS (Genomic Prostate Score), ConfirmMDx, and SelectMDx tests, which utilize genetic and epigenetic biomarkers to support personalized diagnosis and treatment strategies for veteran healthcare.

The initial BPA call, valued at $243,668.52 with a completion date of September 30, 2026, was awarded on a firm fixed-price basis to provide "MDX Health Testing for VISN 19" under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule. This procurement aligns with the VA's efforts to deliver specialized cancer testing services to veterans, with a specific focus on prostate cancer diagnostic testing and other advanced molecular diagnostic capabilities. The original pre-solicitation notice, posted on July 31, 2025, indicated the requirement falls under NAICS code 621511 for Medical Laboratories and PSC code Q301 for Reference Laboratory Testing, suggesting the VA seeks to leverage external laboratory facilities to provide these genetic testing services to the veteran population within VISN 19.

Generated 10/2/25, 10:51 AM